1. Should OCs be withdrawn preoperatively?

   Newsletter Article 12 February 2013 Pages: 2 - 2

2. NSAID use: comments on associated skin disorders and …

   Newsletter Article 12 February 2013 Pages: 2 - 3

3. … concomitant use of gastroprotective agents

   Newsletter Article 12 February 2013 Pages: 3 - 3

4. Recognising Reye’s syndrome in adults

   Newsletter Article 12 February 2013 Pages: 3 - 4

5. Aciclovir

   Newsletter Article 12 February 2013 Pages: 4 - 4

6. Amikacin

   Newsletter Article 12 February 2013 Pages: 4 - 5

7. Aminoglycosides

   Newsletter Article 12 February 2013 Pages: 5 - 5

8. Amiodarone

   Newsletter Article 12 February 2013 Pages: 5 - 5

9. Antiglaucoma agents

   Newsletter Article 12 February 2013 Pages: 5 - 5

10. Antipsychotics

    Newsletter Article 12 February 2013 Pages: 5 - 5

11. Atenolol see Neostigmine interaction

    Newsletter Article 12 February 2013 Pages: 5 - 5

12. Benzoyl peroxide

    Newsletter Article 12 February 2013 Pages: 5 - 5

13. Calcium antagonists

    Newsletter Article 12 February 2013 Pages: 5 - 5

14. Charcoal/sorbitol

    Newsletter Article 12 February 2013 Pages: 5 - 5

15. Cimetidine

    Newsletter Article 12 February 2013 Pages: 5 - 5

16. Cocaine abuse

    Newsletter Article 12 February 2013 Pages: 5 - 5

17. Colchicine overdose

    Newsletter Article 12 February 2013 Pages: 5 - 6

18. Corticosteroids

    Newsletter Article 12 February 2013 Pages: 6 - 6

19. Cyclosporin see Warfarin interaction

    Newsletter Article 12 February 2013 Pages: 6 - 6

20. Diltiazem

    Newsletter Article 12 February 2013 Pages: 6 - 6

21. Diuretics

    Newsletter Article 12 February 2013 Pages: 6 - 6

22. Doxorubicin see Epirubicin/doxorubicin

    Newsletter Article 12 February 2013 Pages: 6 - 6

23. Enalapril

    Newsletter Article 12 February 2013 Pages: 6 - 7

24. Epirubicin

    Newsletter Article 12 February 2013 Pages: 7 - 7

25. Epirubicin/doxorubicin

    Newsletter Article 12 February 2013 Pages: 7 - 7

26. Etretinate see Methotrexate interaction

    Newsletter Article 12 February 2013 Pages: 7 - 7

27. Fenthion poisoning

    Newsletter Article 12 February 2013 Pages: 7 - 7

28. Fluoride

    Newsletter Article 12 February 2013 Pages: 7 - 7

29. Fusidic acid

    Newsletter Article 12 February 2013 Pages: 8 - 8

30. Indapamide

    Newsletter Article 12 February 2013 Pages: 8 - 8

31. Indomethacin

    Newsletter Article 12 February 2013 Pages: 8 - 8

32. Lithium

    Newsletter Article 12 February 2013 Pages: 8 - 8

33. Marijuana

    Newsletter Article 12 February 2013 Pages: 8 - 8

34. Marijuana withdrawal

    Newsletter Article 12 February 2013 Pages: 8 - 8

35. Methotrexate interaction

    Newsletter Article 12 February 2013 Pages: 8 - 8

36. Metoclopramide

    Newsletter Article 12 February 2013 Pages: 8 - 8

37. Morphine

    Newsletter Article 12 February 2013 Pages: 8 - 9

38. Neostigmine interaction

    Newsletter Article 12 February 2013 Pages: 9 - 9

39. Nicardipine

    Newsletter Article 12 February 2013 Pages: 9 - 9

40. Nifedipine

    Newsletter Article 12 February 2013 Pages: 9 - 9

41. Penicillamine

    Newsletter Article 12 February 2013 Pages: 9 - 9

42. Phenothiazines

    Newsletter Article 12 February 2013 Pages: 9 - 9

43. Procaine penicillin

    Newsletter Article 12 February 2013 Pages: 9 - 9

44. Propranolol

    Newsletter Article 12 February 2013 Pages: 9 - 9

45. Propranolol overdose

    Newsletter Article 12 February 2013 Pages: 9 - 10

46. Quinidine

    Newsletter Article 12 February 2013 Pages: 10 - 10

47. Sorbitol see Charcoal/sorbitol

    Newsletter Article 12 February 2013 Pages: 10 - 10

48. Sotalol

    Newsletter Article 12 February 2013 Pages: 10 - 10

49. Tocainide

    Newsletter Article 12 February 2013 Pages: 10 - 10

50. Vancomycin

    Newsletter Article 12 February 2013 Pages: 10 - 10